Holen Sie sich die Stockscreener-App
45.73
7.24%
3.12
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Schroder Investment Management Group Reduces Stock Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock price target raised to $73 from $60 at TD Cowen - Investing.com UK
Vera Therapeutics exec Turner sells $400k in shares - Investing.com
Vera Therapeutics Executive Sells 10,000 Shares - TradingView
Will Vera Therapeutics Inc. stock reach Wall Street targets2025 Institutional Moves & Consistent Growth Stock Picks - Newser
Why Vera Therapeutics Inc. stock is trending among retail tradersMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
Is Vera Therapeutics’ Recent 69% Surge Justified by Its Valuation in 2025? - Yahoo Finance
Vera Therapeutics rises 19.2% - MSN
Vera Therapeutics Inc. (VERA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vera Therapeutics Stock Soars: Time to Buy? - StocksToTrade
Vera Therapeutics (VERA): Reassessing Valuation After Positive Phase 3 IgAN Data and Accelerated FDA Path - Yahoo Finance
Is Vera Therapeutics (VERA) Quietly Recasting Its Commercial Strategy With the Meyers Board Appointment? - Yahoo Finance
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 6.7%Here's What Happened - MarketBeat
Vera Therapeutics, Inc. (VERA): A Top Gainer with Promising FDA Approvals - Meyka
Vera Therapeutics: Stock Rises As IgAN Approval Chances IncreaseI'm On Sidelines (VERA) - Seeking Alpha
American Century Companies Inc. Raises Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Rocked the Market on Tuesday - Finviz
Vera Therapeutics stock price target reiterated at $73 by Raymond James - Investing.com Canada
Vera’s Surge: What It Means For Investors - timothysykes.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Quadrature Capital Ltd Invests $852,000 in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Inc. stock is recommended by analystsWeekly Profit Summary & Safe Entry Trade Reports - Newser
Discipline and Rules-Based Execution in VERA Response - news.stocktradersdaily.com
Will Vera Therapeutics (VERA) Strengthen Its Commercial Edge With Board Appointment of James R. Meyers? - Sahm
Vera Therapeutics Contributes To Nasdaq Index Growth In Biotech - Kalkine Media
KDIGO guidelines positive for Vera Therapeutics, says Cantor Fitzgerald - MSN
XTX Topco Ltd Grows Position in Vera Therapeutics, Inc. $VERA - MarketBeat
A Fresh Look at Vera Therapeutics (VERA) Valuation as Analyst Optimism Follows Board Addition and FDA Milestone - Sahm
Geode Capital Management LLC Increases Stock Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock steady as H.C. Wainwright reiterates Buy rating By Investing.com - Investing.com Canada
Wolfe Research Initiates Coverage of Vera Therapeutics (VERA) with Outperform Recommendation - MSN
Polycythemia Vera Pipeline 2025: MOA and ROA Insights, Clinical - openPR.com
Earnings Report: Is Vera Therapeutics Inc. stock a top momentum play2025 Short Interest & AI Based Buy and Sell Signals - BỘ NỘI VỤ
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 11.8%Should You Buy? - MarketBeat
Vera Thera files BLA for atacicept in IgAN - The Pharma Letter
Why Vera Therapeutics Stock Crushed it Today - Finviz
Vera Therapeutics appoints former Gilead executive to board By Investing.com - Investing.com Nigeria
Vera Therapeutics Appoints James R. Meyers to Board - TipRanks
Vera Therapeutics Stock Unveiled: What Lies Ahead? - timothysykes.com
Vera Therapeutics Form 4 shows 25,000 director stock options - Stock Titan
New Vera Therapeutics (VERA) director reports zero beneficial ownership - Stock Titan
Vera Therapeutics Appoints James R. Meyers to Board of Directors - TradingView
Vera Therapeutics appoints James R. Meyers director and audit member - Stock Titan
Vera Therapeutics appoints former Gilead executive to board - Investing.com
Vera Therapeutics Appoints Biopharmaceutical Veteran James R. Meyers to Board of Directors - Quiver Quantitative
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors - GlobeNewswire
After pivot, this Bay Area CEO says company is hiring and 'almost to the starting line'San Francisco Business Times - The Business Journals
Vera Therapeutics stock undervalued with strong IgAN market potential By Investing.com - Investing.com UK
Vera Therapeutics Reports Increased Losses Amid R&D Expansion - MSN
Vera Therapeutics Executive Sells Shares to Cover Tax Obligations - TradingView
[Form 4] Vera Therapeutics, Inc. Insider Trading Activity - Stock Titan
Officer Carter Files To Sell 3,864 Of Vera Therapeutics Inc [VERA] - TradingView
Vera Therapeutics to Participate at Upcoming Investor Conferences - The Manila Times
Vera Therapeutics to Present at Upcoming Investor Conferences in December 2025 - Quiver Quantitative
Vera Therapeutics (Nasdaq: VERA) joins Evercore and Citi 2025 healthcare investor events - Stock Titan
The Bull Case For Vera Therapeutics (VERA) Could Change Following Positive Phase 3 Atacicept Kidney Data - Sahm
BK Virus Infection Market Trends, Strategies and Business Prospects 2025-2035 - GlobeNewswire Inc.
Will Vera Therapeutics Inc. stock benefit from automation2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com
How high can Vera Therapeutics Inc. stock goJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Behavioral Patterns of VERA and Institutional Flows - news.stocktradersdaily.com
0.83%
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):